Biphasic insulin-releasing effect of BTS 67 582 in rats

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 12, 1998, Pages 1357-1360

  Storey, David A ^a   Bailey, Clifford J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYL 2 (2 MORPHOLINOPHENYL)GUANIDINE FUMARATE; ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

EID: 0345004068     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03359.x     Document Type: Article

References (16)

1. Bailey, C. J., Wilcock, C., Day, C. (1992) Effect of metformin on glucose metabolism in the splanchnic bed. Br. J. Pharmacol. 105: 1013-1099
2. Basabe, J. C., Farina, J. M. S., Chieri, R. A. (1976) Studies on the dynamics and mechanism of glibenclamide-induced insulin secretion. Horm. Metab. Res. 8: 413-419
3. Byrom, W. D., Rotherham, N. E., Bratty, J. R. (1994) Relationship between hypoglycaemic responses and plasma concentration of BTS 67 582 in healthy volunteers. Br. J. Clin. Pharmacol. 38: 433-439
4. Byrom, W. D., Weil, A., Brown, T. J., Bratty, J. R. (1996) BTS 67 582 improves 24-h plasma glucose control and post-prandial insulin secretion in NIDDM patients. Diabetologia 39 (Suppl. 1): A44
5. Dickinson, K., North, T. J., Sills, S., Antony, D. M., Lock, J. I., Vowles, D. T., Jones, R. B. (1997) BTS 67 582 stimulates insulin secretion from perfused rat pancreatic islets. Eur. J. Pharmacol. 339: 69-76
6. Dunne, M. J., Kane, C., Harding, E. A., Jagger, J. H., Jones, R. B., Ashcroft, S. J. H. (1995) BTS 67 582, a novel insulin-releasing agent. Diabetic Med. 12: S31-S32
7. Gerich, J. E. (1989) Oral hypoglycemic agents. New Engl. J. Med. 321: 1231-1245
8. Gorus, F. K., Schuit, F. C., Veld, P. A. I., Gepts, W., Pipeleers, D. G. (1988) Interaction of sulfonylureas with pancreatic β-cells. Diabetes 37: 1090-1095
9. Grodsky, G. M. (1994) An update on implications of phasic insulin secretion. In: Flatt, P. R., Lenzen, S. (eds) Insulin Secretion and Pancreatic β-cell Research, Smith-Gordon, London, pp 421 -430
10. Groop, L. C. (1992) Sulfonylureas in NIDDM. Diabetes Care 15: 737-754
11. 2+ in isolated insulin-secreting cells by BTS 67 582, a novel hypoglycaemia-inducing agent. Diabetologia 39 (Suppl. 1): A43
12. Jones, R. B., Dickinson, K., Anthony, D. M., Marita, A. R., Kaul, C. L., Buckett, W. R. (1997) Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats. Br. J. Pharmacol. 120: 1135-1143
13. Nelson, D. A., Aguilar-Bryan, L., Raef, H., Boyd, A. E. (1992) Molecular mechanisms of sulphonylurea action in the pancreatic β-cell. In: Flatt, P. R. (ed.) Nutrient Regulation of Insulin Secretion, Portland Press, London, pp 319-339
14. Page, T., Bailey, C. J. (1997) Glucose-lowering effect of BTS 67 582. Br. J. Pharmacol. 122: 1464-1468
15. Panten, U., Burgfeld, J., Goerke, F., Rennicke, M., Schwanstecher, M., Wallasch, A., Zunkler, B. J., Lenzen, S. (1989) Control of insulin secretion by sulphonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem. Pharmacol. 38: 1217-1229
16. Stevens, J. F. (1971) Determination of glucose by an automatic analyser. Clin. Chim. Acta 32: 199-201